No shortcuts. No shortages.
Pharmaceutical companies balance continuity of supply with strict quality and regulatory control, often across a global network of external manufacturers.
Pharma supply chains run on long lead times, qualified suppliers, batch release processes, and market-by-market regulatory requirements. Much of manufacturing is outsourced to CMOs and CDMOs. Product lifecycles bring launches, tech transfers, patent expiries, and transitions, each with supply implications. And a shortage isn't just lost revenue. It affects patients.
What pharma supply leaders are focused on
It's a responsibility to patients. These priorities come up in almost every conversation:
- Preventing shortages and protecting continuity of supply.
- External manufacturing visibility across CMOs and CDMOs.
- Batch release and quality status reflected in the plan.
- Serialization and traceability across markets.
- Validated modernization of ERP and planning platforms.
Across the pharma supply chain
A pharmaceutical supply chain is only as strong as its weakest link, whether that's an API supplier, a CMO, a release step, or a cold chain lane. We work across every stage:
- Plan: supply planning with quality and release status built in, plus launch and lifecycle transition planning.
- Source: API and material supplier risk, and CMO and CDMO collaboration.
- Make: production planning across internal and external sites.
- Deliver: serialization, track and trace, and cold chain distribution.
How pharma companies measure progress
Backorders and shortage events, batch release cycle time reflected in the plan, CMO on-time performance, forecast accuracy, inventory days, and inspection readiness.
What leaders ask about Pharmaceuticals
Practical answers to the questions that often shape the first conversation.
How can pharma companies reduce the risk of drug shortages?+
Connect supply, quality, and release data into planning, monitor supplier and CMO risk early, hold the right strategic buffers, and model scenarios before disruptions hit.
How do you plan a product launch or tech transfer?+
Plan demand, supply, qualification, and regulatory milestones together, with buffers for validation and release timelines, and clear decision points if dates move.
How do you keep a validated system compliant after go-live?+
With controlled change processes, clear ownership, ongoing monitoring of adoption and process adherence, and managed services that understand validation requirements.